ASX - By Stock
|
MVP |
Re:
Ann: Resignation of Director
|
|
Kenny73
|
9 |
5.5K |
8 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
9
|
5.5K
|
8
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
Kenny73
|
194 |
86K |
2 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
194
|
86K
|
2
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
Kenny73
|
194 |
86K |
4 |
09/04/23 |
09/04/23 |
ASX - By Stock
|
194
|
86K
|
4
|
|
ASX - By Stock
|
EXL |
Re:
News: EXL Elixinol Wellness Seeks Trading Halt
|
|
Kenny73
|
6 |
3.1K |
0 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
6
|
3.1K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
Kenny73
|
194 |
86K |
5 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
194
|
86K
|
5
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
Kenny73
|
194 |
86K |
3 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
194
|
86K
|
3
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
Kenny73
|
194 |
86K |
8 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
194
|
86K
|
8
|
|
ASX - By Stock
|
EXL |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Kenny73
|
11 |
5.4K |
0 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
11
|
5.4K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: 2023 Half Year ASX Announcement
|
|
Kenny73
|
31 |
15K |
11 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
31
|
15K
|
11
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Half Year Results Announcement Details
|
|
Kenny73
|
63 |
19K |
9 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
63
|
19K
|
9
|
|
ASX - By Stock
|
MVP |
Re:
Green whistle in action tonight at the A league soccer
|
|
Kenny73
|
20 |
5.1K |
1 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
20
|
5.1K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
MVP chart thoughts.
|
|
Kenny73
|
8 |
4.7K |
5 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
8
|
4.7K
|
5
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
Kenny73
|
194 |
86K |
17 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
194
|
86K
|
17
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
Kenny73
|
139 |
83K |
6 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
139
|
83K
|
6
|
|
ASX - By Stock
|
MVP |
Re:
Rights Issue
|
|
Kenny73
|
7 |
2.8K |
6 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
7
|
2.8K
|
6
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Investor Presentation - $30m Capital Raise and FY22 Guidance
|
|
Kenny73
|
23 |
13K |
17 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
23
|
13K
|
17
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Trading Halt
|
|
Kenny73
|
27 |
11K |
6 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
27
|
11K
|
6
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Investor Presentation - $30m Capital Raise and FY22 Guidance
|
|
Kenny73
|
23 |
13K |
5 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
23
|
13K
|
5
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
Kenny73
|
139 |
83K |
11 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
139
|
83K
|
11
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
Kenny73
|
139 |
83K |
8 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
139
|
83K
|
8
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
Kenny73
|
139 |
83K |
19 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
139
|
83K
|
19
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Green Whistle gets the Green Light - FDA Clears US Trial
|
|
Kenny73
|
139 |
83K |
9 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
139
|
83K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
Study 7 clinical study
|
|
Kenny73
|
16 |
12K |
2 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
16
|
12K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: ColoSTAT Prototype Complete, Outperforms FIT
|
|
Kenny73
|
24 |
8.9K |
4 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
24
|
8.9K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: ColoSTAT Prototype Complete, Outperforms FIT
|
|
Kenny73
|
24 |
8.9K |
1 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
24
|
8.9K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Ethics Approval Received, New Clinical Trial Site Added
|
|
Kenny73
|
13 |
6.5K |
1 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
13
|
6.5K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Ethics Approval Received, New Clinical Trial Site Added
|
|
Kenny73
|
13 |
6.5K |
2 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
13
|
6.5K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Final Two Adjunct Biomarkers Technically Validated
|
|
Kenny73
|
13 |
6.3K |
4 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
13
|
6.3K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Final Two Adjunct Biomarkers Technically Validated
|
|
Kenny73
|
13 |
6.3K |
6 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
13
|
6.3K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Valuation Two More Successful Tests
|
|
Kenny73
|
24 |
8.4K |
7 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
24
|
8.4K
|
7
|
|
ASX - By Stock
|
GFS |
Re:
What now?!
|
|
Kenny73
|
18 |
13K |
0 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
18
|
13K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
http://sprout8.com/rhy-research-report/
|
|
Kenny73
|
1 |
737 |
0 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
1
|
737
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Valuation Two More Successful Tests
|
|
Kenny73
|
24 |
8.4K |
2 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
24
|
8.4K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Successfully Validates Two Adjunct Biomarkers
|
|
Kenny73
|
13 |
3.2K |
6 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
13
|
3.2K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Entitlement Offer - Results
|
|
Kenny73
|
7 |
2.2K |
1 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Results of Meeting
|
|
Kenny73
|
12 |
2.9K |
0 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
12
|
2.9K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Results of Meeting
|
|
Kenny73
|
12 |
2.9K |
3 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
12
|
2.9K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Placement & Rights Offer to raise approximately $6 million
|
|
Kenny73
|
63 |
17K |
2 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
63
|
17K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Placement & Rights Offer to raise approximately $6 million
|
|
Kenny73
|
63 |
17K |
3 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
63
|
17K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Placement & Rights Offer to raise approximately $6 million
|
|
Kenny73
|
63 |
17K |
2 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
63
|
17K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Placement & Rights Offer to raise approximately $6 million
|
|
Kenny73
|
63 |
17K |
2 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
63
|
17K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Trading Halt
|
|
Kenny73
|
22 |
4.4K |
1 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
22
|
4.4K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Successfully Validates Key Biomarker
|
|
Kenny73
|
49 |
14K |
2 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
49
|
14K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Successfully Validates Key Biomarker
|
|
Kenny73
|
49 |
14K |
2 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
49
|
14K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Successfully Validates Key Biomarker
|
|
Kenny73
|
49 |
14K |
2 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
49
|
14K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Successfully Validates Key Biomarker
|
|
Kenny73
|
49 |
14K |
3 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
49
|
14K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Successfully Validates Key Biomarker
|
|
Kenny73
|
49 |
14K |
2 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
49
|
14K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4D and Half Yearly Report and Accounts
|
|
Kenny73
|
12 |
87K |
3 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
12
|
87K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4D and Half Yearly Report and Accounts
|
|
Kenny73
|
12 |
87K |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
12
|
87K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4D and Half Yearly Report and Accounts
|
|
Kenny73
|
12 |
87K |
1 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
12
|
87K
|
1
|
|